BioSpace News Archive

Sage Therapeutics, Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced it will host a live webcast on Monday, August 10, 2020, at 8:30 a.m. ET to announce second quarter 2020 financial results and discuss recent business updates.

Immuron’s IMM-124E used to manufacture Travelan® and Protectyn® demonstrates antiviral activity against the COVID-19 virus in laboratory studies

World’s first single-use two channel ECG and heart rate biosensor provides 72-hour patient monitoring with remote data access in ambulatory, hospital and home settings

Phase 2 Trial for Patients with Solid Tumors of Any Origin Bearing NRG1 Fusions

DiNAQOR AG, a gene therapy platform company, announced the expansion of its global research and development operations with a new facility in the Bio-Technopark Schlieren-Zürich.

$32.5M Series A Financing Led by Aisling Capital, Vertex Ventures HC, Qiming Venture Partners USA, Driehaus Capital Management, and BVF Partners

CIVCO Radiotherapy and Mevion Medical Systems are pleased to announce that Universal Couchtop™ is now validated and available on MEVION S250™ Series Proton Therapy Systems.

United Health Products, Inc., announced that it has filed a non-provisional patent application with the U.S. Patent & Trademark Office for the hydrocolloid format of its HemoStyp oxidized regenerated cellulose product, and has also filed a separate application under the Patent Cooperation Treaty with the World Intellectual Property Organization.

One-Second Glaucoma Laser Treatment nearing reality for millions of Glaucoma patients

PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2 IgG using its GSP ® /DELFIA ® platform, enabling processing of up to 5,000 samples per day. The finger-prick